BSECompany Update22 Jun 2026 · 22 Jun 2026, 04:09 pm

Outcome of the Rights issue Committee Meeting Held on 22nd June, 2026

Indrayani Biotech Ltd · 526445

✦ AI Summary▼ NegativeFundraise

Indrayani Biotech Ltd has announced the indefinite postponement of its partly paid-up Rights Issue. The Rights Issue Committee, at its meeting on June 22, 2026, decided to defer the schedule until further notice, which was previously extended to close on July 24, 2026. While the revised opening and closing dates will be intimated later, the offer price and rights entitlement ratio approved earlier will remain unchanged.

Analysis Scores

Earnings Impact4/10
Growth Catalyst3/10
Governance Concern4/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact5/10
Market Sentiment3/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indrayani Biotech Ltd - 526445 - Outcome Of The Rights Issue Committee Meeting Held On 22Nd June, 2026

Attachments (1)

📄

09dc0e69-b516-4313-858c-66063b7337fb.pdf

pdf

Download →
View document text
IBL Indrayani Date: June 22, 2026 Listing Operations Department, ) BSE Limited, - P.J. Towers, Dalal Street, Mumbai — 400 001. Scrip ID: 526445 ISIN: INE007C01021 Subject: Outcome of the Rights Issue Committee - ("'Committee') of Indrayani Biotech Limited ""Company") for Postponement of Rights issue schedule. Dear Sir/Madam, This outcome is in continuation of the earlier outcomes dated April 09, 2026 and May 25, 2026, wherein the issue schedule and other terms and conditions relating to Rights issue were finalised This is to inform the eligible equity shareholders of the Company that the Rights Issue Committee, at its meeting held on June 22, 2026, has decided to postpone the schedule of the partly paid-up Rights Issue. The Rights Issue schedule, which was initially scheduled to open on Wednesday, May 27, 2026 and close on Thursday, June 25, 2026, and was subsequently extended from Thursday, June 25, 2026 to Friday, July 24, 2026, stands postponed until further notice. The revised issue opening and closing dates shall be intimated separately once finalized by the Rights Issue Committee. Further, the terms relating to the offer price and rights entitlement ratio will remain the same as approved by the Rights Issue Committee and intimated to the stock exchange earlier. The updated issue documents shall be made available on the website of the Stock Exchange at www.bseindia.com and on the website of the Company at www.indrayani.com upon finalization of the revised issue schedule. We request you to take the above on record and that the same be treated as compliance under the applicable regulation(s) under the SEBI Listing Regulations. The meeting commenced at 3.30 PM and concluded at 3.55 PM You are requested to take the above on record and acknowledge. Thanks & Regards, For Indrayani Biotech Limited Swaminathan. G ‘Wholetime Director DIN: 02481041 IDCO Electronics Complex, Thiru Vi Ka Industrial Estate, Guindy, Chennai 600032 91-44-24463751 / 22502146 www.indraya ndrayani.com CIN 29301